Skip to content

Blended Vegetable and Fruit Juice Containing Lactobacillus paracasei Lowers Blood Lipid Levels and Oxidative Stress Markers in Thai Dyslipidemia Subjects: A Randomised Controlled Trial

Blended Vegetable and Fruit Juice Containing Lactobacillus paracasei Lowers Blood Lipid Levels and Oxidative Stress Markers in Thai Dyslipidemia Subjects: A Randomised Con-trolled Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220109001
Enrollment
20
Registered
2022-01-09
Start date
2018-09-24
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia (high level of low-density lipoprotein cholesterol (LDL-C) in the range of 130-160 mg/dL) Clinical trial, Dyslipidemia, Lactobacillus paracasei, Probiotic, Vegetable and fruit juice

Interventions

The placebo group of eligible participants received two bottles of blended vegetable and fruit juice with probiotic L. paracasei for 30 days treatment. The participants drank the juice 30 minutes b
Blended vegetable and fruit juice without probiotic L. paracasei ,Blended vegetable and fruit juice with probiotic L. paracasei

Sponsors

Bhumibol Adulyadej Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The subjects were required to be aged at least 18 years., 2. The subjects had a high level of low- density lipoprotein cholesterol (LDL-C) in the range of 130-160 mg/dL according to the National Cholesterol Education Program (NCEP)., 3. The subjects never received medical treatment for dyslipidemia.

Exclusion criteria

Exclusion criteria: 1.Having family history of dyslipidemia, 2.Having gastrointestinal surgery, 3. Suffering from metabolic disorders, cardiovascular disease, thyroid disorder, kidney disease, and liver disease, 4. Having been treated with prebiotic and/or probiotic and/or nutrition supplements, 5. Taking other drugs which possibility affect the lipid metabolism, 6.Smoking and drinking alcohol during the clinical trial.

Design outcomes

Primary

MeasureTime frame
lipid profile and bile acid at 30 days after end of the intervention TC (mg/dL) LDL-C (mg/dL) HDL-C (mg/dL) TG (mg/dL) and BA (micromole/L)

Secondary

MeasureTime frame
Oxidative stress enzymes at 30 days after end of the intervention CAT (unit/mL) GPx (unit/mL) SOD (unit/mL)

Countries

Thailand

Contacts

Public ContactPattharaparn Siripun

Pharmaceutical Division, Bhumibol Adulyadej Hospital

pattharaparn@gmail.com6625347442

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026